Branded Pharma And Generics Industries At Odds Over UK VPAG Framework

 
• By Eliza Slawther and Dave Wallace
  
The UK branded drug and generics industries have different views on rebate rates under the VPAG scheme (Shutterstock)

More from Government Payers

More from Market Access